The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts

Journal of Cell Biology

Volumn 159, Issue 1, 2002, Pages 113-122

  Martin, Bernd ^a   Schneider, Richard ^a   Janetzky, Stefanie ^b   Waibler, Zoe ^a   Pandur, Petra ^c   Kühl, Michael ^c   Behrens, Jürgen ^b   Von Mark, Klaus Der ^b   Starzinski Powitz, Anna ^a   Wixler, Viktor ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

catenin TCF complex; DRAL; FHL2; Myogenic differentiation; Repression of transcription

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BINDING PROTEIN; COMPLEMENTARY DNA; LIM PROTEIN; PLAKOGLOBIN; PROTEIN FHL2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA LIBRARY; EMBRYO; GENE REPRESSION; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; RHABDOMYOSARCOMA; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; XENOPUS;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; CYTOSKELETAL PROTEINS; GENES, REPORTER; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOBLASTS; OOCYTES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; XENOPUS LAEVIS; XENOPUS PROTEINS;

ANIMALIA; ARMADILLO; MAMMALIA;

EID: 0037078329     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200202075     Document Type: Article

References (53)

1. Aberle, H., A. Bauer, J. Stappert, A. Kispert, and R. Kemler. 1997. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16;3797-3804.
2. Akiyama, T. 2000. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 11:273-282.
3. Baniahmad, A., X. Leng, T.P. Burris, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76-86.
4. Beckerle, M.C. 1997. Zyxin: zinc fingers at sites of cell adhesion. Bioessays. 19:949-957.
5. Behrens, J., J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:638-642.
6. Brand-Saberi, B., and B. Christ. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296:199-212.
7. Chan, K.K., S.K. Tsui, S.M. Ngai, S.M. Lee, M. Kotaka, M.M. Waye, C.Y. Lee, and K.P. Fung. 2000. Protein-protein interaction of FHL2, a LIM-domain protein preferentially expressed in human heart, with hCDC47. J. Cell. Biochem. 76:499-508.
8. Chu, P.H., W.M. Bardwell, Y. Gu, J. Ross, Jr., and J. Chen. 2000a. FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell. Biol. 20:7460-7462.
9. Chu, P. H., P. Ruiz-Lozano, Q. Zhou, C. Cai, and J. Chen. 2000b. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech. Dev. 95:259-265.
10. Cossu, G., and U. Borello. 1999. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18:6867-6872.
11. Dawid, I.B., J.J. Breen, and R. Toyama. 1998. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14:156-162.
12. Fimia, G.M., D. De Cesare, and P. Sassone-Corsi. 1999. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature. 398:165-169.
13. Fimia, G.M., D. De Cesare, and P. Sassone-Corsi. 2000. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol. Cell. Biol. 20:8613-8622.
14. Galceran, J., I. Farinas, M.J. Depew, H. Clevers, and R. Gtosschedl. 1999. Wnt3a-/-like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev. 13:709-717.
15. Genini, M., P. Schwalbe, F.A. Scholl, A. Remppis, M.G. Mattei, and B.W. Schafer. 1997. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol. 16:433-442.
16. Goichberg, P., M. Shtutman, A. Ben-Ze'ev, and B. Geiger. 2001. Recruitment of β-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction. J. Cell Sci. 114:1309-1319.
17. Hecht, A., and R. Kemler. 2000. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep. 1:24-28.
18. Hinck, L., I.S. Nathke, J. Papkoff, and W.J. Nelson. 1994. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 125:1327-1340.
19. Hsu, S.C., J. Galceran, and R. Grosschedl. 1998. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol. Cell. Biol. 18:4807-4818.
20. Huber, O., R. Korn, J. McLaughlin, M. Ohsugi, B.G. Herrmann, and R. Kemler. 1996. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59:3-10.
21. Hulsken, J., W. Birchmeier, and J. Behrens. 1994. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J. Cell Biol. 127:2061-2069.
22. Irintchev, A., M. Zweyer, and A. Wernig. 1997. Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscul. Disord. 7:117-125.
23. Kaufmann, U., J. Kirsch, A. Irintchev, A. Wernig, and A. Starzinski-Powitz. 1999. The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: implications for the fusion of myoblasts. J. Cell Sci. 112:55-68.
24. Kaufmann, U., C. Zuppinger, Z. Waibler, M. Rudiger, C. Urbich, B. Martin, B.M. Jockusch, H. Eppenberger, and A. Starzinski-Powitz. 2000. The armadillo repeat region targets ARVCF to cadherin-based cellular junctions. J. Cell Sci. 113:4121-4135.
25. Kemler, R. 1993. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9:317-321.
26. Kong, Y., J.M. Shelton, B. Rothermel, X. Li, J.A. Richardson, R. Bassel-Duby, and R.S. Williams. 2001. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to β-adrenergic stimulation. Circulation. 103:2731-2738.
27. Lassar, A.B., B.M. Paterson, and H. Weintraub. 1986. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell. 47:649-656.
28. Miller, J.R., and R.T. Moon. 1997. Analysis of the signaling activities of localization mutants of β-catenin during axis specification in Xenopus. J. Cell Biol. 139:229-243.
29. Molenaar, M., M. van de Wetering, M. Oosterwegel, J. Peterson-Maduro, S. Godsave, V. Korinek, J. Roose, O. Destree, and H. Clevers. 1996. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell. 86:391-399.
30. Molkentin, J.D., and E.N. Olson. 1996. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA. 93:9366-9373.
31. Morgan, M.J., and A.J. Madgwick. 1999. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle. Biochem. Biophys. Res. Commun. 255:245-250.
32. Muller, J.M., U. Isele, E. Metzger, A. Rempel, M. Moser, A. Pscherer, T. Breyer, C. Holubarsch, R. Buettner, and R. Schule. 2000. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:359-369.
33. Muller, J.M., E. Metzger, H. Greschik, A.K. Bosserhoff, L. Mercep, R. Buettner, and R. Schule. 2002. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 21:736-748.
34. Munsterberg, A.E., J. Kitajewski, D.A. Bumcrot, A.P. McMahon, and A.B. Lassar. 1995. Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev. 9:2911-2922.
35. Nadal-Ginard, B. 1978. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 15:855-864.
36. Nusse, R. 1997. A versatile transcriptional effector of Wingless signaling. Cell. 89:321-323.
37. Ozawa, M., and R. Kemler. 1992. Molecular organization of the uvomorulin-catenin complex. J. Cell Biol. 116:989-996.
38. Petropoulos, H., and I.S. Skerjanc. 2002. β-Catenin is essential and sufficient for skeletal myogenesis in P19 cells. J. Biol. Chem. 277:15393-15399.
39. Redfield, A., M.T. Nieman, and K.A. Knudsen. 1997. Cadherins promote skeletal muscle differentiation in three-dimensional cultures. J. Cell Biol. 138:1323-1331.
40. Scholl, F.A., P. McLoughlin, E. Ehler, C. de Giovanni, and B.W. Schafer. 2000. DRAL is a p53-responsive gene whose four and a half LIM-domain protein product induces apoptosis. J. Cell Biol. 151:495-506.
41. Seidensticker, M.J., and J. Behrens. 2000. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta. 1495:168-182.
42. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:5522-5527.
43. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1022-1024.
44. Tago, K., T. Nakamura, M. Nishita, J. Hyodo, S. Nagai, Y. Murata, S. Adachi, S. Ohwada, Y. Morishita, H. Shibuya, and T. Akiyama. 2000. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein. Genes Dev. 14:1741-1749.
45. Tanahashi, H., and T. Tabira. 2000. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. Hum. Mol. Genet. 9:2281-2289.
46. Taniguchi, Y., T. Furukawa, T. Tun, H. Han, and T. Honjo. 1998. LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol. Cell. Biol. 18:644-654.
47. Tetsu, O., and F. McCormick. 1999. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422-426.
48. Wei, Q, and B.M. Paterson. 2001. Regulation of MyoD function in the dividing myoblast. FEBS Lett. 490:171-178.
49. Wixler, V., D. Geerts, E. Laplantine, D. Westhoff, N. Smyth, M. Aumailley, A. Sonnenberg, and M. Paulsson. 2000. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several α and β integrin chains and is recruited to adhesion complexes. J. Biol. Chem. 275:33669-33678.
50. Yost, C., M. Torres, J.R. Miller, E. Huang, D. Kimelman, and R.T. Moon. 1996. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1443-1454.
51. Yun, K., and B. Wold. 1996. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:877-889.
52. Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, and A. Starzinski-Powitz. 1995. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 108:2973-2981.
53. Zhurinsky, J., M. Shtutman, and A. Ben-Ze'ev. 2000. Plakoglobin and β-catenin: protein interactions, regulation and biological roles. J. Cell Sci. 113:3127-3139.